JHS Svendgaard Laboratories Limited (NSE:JHS)
India · Delayed Price · Currency is INR 8.24
+0.02 (0.24%)
Nov 11, 2026, 2:57 PM IST
NSE:JHS Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,074 | 1,017 | 922.91 | 728.93 | 911.59 | 872.11 |
Revenue Growth | 13.28% | 10.23% | 26.61% | -20.04% | 4.53% | -13.63% |
Gross Profit Gross Profit Growth | 363.32 | 365 | 312.49 | 287.18 | 280.2 | 251.39 |
Operating Income Operating Income Growth | -42.58 | -39.91 | -108.75 | -45.42 | -86.9 | -41.87 |
Net Income Net Income Growth | -11.83 | -19.22 | -197.44 | -40.58 | -40.52 | -40.52 |
Earnings Per Share EPS Growth | -0.14 | -0.22 | -2.37 | -0.52 | -0.52 | -0.63 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
India India Growth | 986.55 | 880.95 | 689 | 839.76 |
UAE UAE Growth | - | 0.88 | 0 | 6.57 |
Italy Italy Growth | 23.71 | 35.57 | 9.62 | - |
Nepal Nepal Growth | 1.34 | 2.57 | 3.36 | 1.21 |
USA USA Growth | 5.35 | - | 2.4 | 0.02 |
Other Other Growth | 0 | 0 | 3.6 | 0.6 |
Total Total Growth | 1,017 | 919.97 | 707.98 | 848.15 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 49.26 | 172.44 | 185.15 | 94.56 | 384.26 | 80.19 |
Total Debt Total Debt Growth | 142.44 | 148.51 | 64.59 | 51.29 | 155.09 | 61.82 |
Net Cash (Debt) Net Cash Growth | -93.18 | 23.92 | 120.57 | 43.27 | 229.17 | 18.37 |
Net Cash Growth | - | -80.16% | 178.62% | -81.12% | 1147.25% | -88.53% |
Net Cash Per Share Net Cash Per Share Growth | -1.10 | 0.27 | 1.45 | 0.55 | 2.92 | 0.29 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -81.46 | -26.58 | -51.78 | -91.77 | 232.86 | -91.36 |
Capital Expenditures CapEx Growth | -133.46 | -88.14 | -105.33 | -315.33 | -143.44 | -67.39 |
Free Cash Flow Free Cash Flow Growth | -214.92 | -114.72 | -157.11 | -407.1 | 89.43 | -158.75 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 33.83% | 35.88% | 33.86% | 39.40% | 30.74% | 28.83% |
Operating Margin | -3.96% | -3.92% | -11.78% | -6.23% | -9.53% | -4.80% |
Pretax Margin | -3.02% | -2.25% | -13.55% | -4.70% | -10.66% | 0.12% |
Profit Margin | -1.10% | -1.89% | -21.39% | -5.57% | -4.45% | -4.65% |
FCF Margin | -20.01% | -11.28% | -17.02% | -55.85% | 9.81% | -18.20% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Forward PE | - | 28.08 | 28.08 | 28.08 | 28.08 | 28.08 |
P/FCF Ratio | - | - | - | - | 11.25 | - |
PS Ratio | 0.67 | 0.56 | 1.04 | 1.74 | 1.10 | 1.53 |